Veracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $16.4 million versus the consensus estimate of $17.69 million.

GUIDANCE:

Veracyte sees FY2017 revenue of $76-84 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.